SEC Tracker
Get the app

Alumis ALMS

Alumis filed SCHEDULE 13D

Ownership stake disclosure by Samsara BioCapital, L.P.

Form
Schedule 13D
Filed
Importance
Notable
  1. Form Type: SCHEDULE 13D
  2. Filing Date: Nov 24, 2025

Written from the Schedule 13D on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Alumis files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Crescent Biopharma CBIO public float $177M, Jun 30, 2025
  2. Editas Medicine EDIT public float $191M, Jun 30, 2025
  3. Omeros OMER public float $172M, Jun 30, 2025
  4. Palvella Therapeutics PVLA public float $197M, Jun 30, 2025
  5. Lexicon Pharmaceuticals LXRX public float $170M, Jun 30, 2025